Breast cancer xenografts using HCC1935 with mutated BRCA1 showed complete inhibition of tumor growth upon treatment with cisplatin whereas only partial response in xenografts that had the wild-type BRCA1 reconstituted. The gene discussed is BRCA1; the disease is neoplasm.